Ru binding to RNA following treatment with the antimetastatic prodrug NAMI-A in Saccharomyces cerevisiae and in vitro

A Phase I and Pharmacological Study with Imidazolium-<b> <i>trans-</i> </b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research · 2004 · 820 citations · Full text

Tumor pH controls the <i>in vivo</i> efficacy of weak acid and base chemotherapeutics

Leo E. Gerweck, Shashirekha Vijayappa, Sergey V. Kozin · Molecular Cancer Therapeutics · 2006 · 349 citations

Structure and bonding in metal sulfoxide complexes

Mario Calligaris · Coordination Chemistry Reviews · 1996 · 328 citations

Inorganic Chemistry, Engineering, Coordination Complex +5

Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology

Michael J. Hannon · Pure and Applied Chemistry · 2007 · 310 citations · Full text

Chemoprevention Strategy, Critical Review, Chemistry +19

Development of Organometallic Ruthenium−Arene Anticancer Drugs That Resist Hydrolysis

Wee Han Ang, Elisa Daldini, C. Scolaro et al. · Inorganic Chemistry · 2006 · 225 citations · Full text